With this concern in mind, and considering the fact that CXCR4 is a major receptor of CXCL12, we further tested whether artificial overexpression of ligand CXCL12 in macrophages can prevent the resensitization of cancer cells to docetaxel in the presence of pexidartinib. The gene discussed is CXCR4; the disease is cancer.